Wellster Healthtech Group

What Wellster Healthtech Group does

Wellster Healthtech Group is a Munich-based Direct-to-Patient digital health platform founded in 2018 by Dr. Manuel Nothelfer and Nico Hribernik. The company operates a multi-brand telemedicine ecosystem spanning eight consumer-facing portals — GoSpring (men's health/erectile dysfunction), GoLighter (GLP-1 obesity therapy), MySummer (women's health), MySpring (hair loss), GoEasy (medical cannabis), Easy-Testen (medical self-tests), Apons, and Wellster Medical — covering distinct health verticals under shared medical governance. Underlying technology combines synchronous and asynchronous telemedicine pathways with structured patient triage and a Real-World Evidence data infrastructure built from millions of anonymized treatment data points, with data processed on German servers and clinical oversight provided by a German-based Medical Advisory Board.

The company generates revenue through per-consultation telemedicine fees, prescription medication fulfillment (transaction fees), and OTC product sales, served exclusively via owned digital channels with no third-party distribution. Patient acquisition runs through a multi-channel marketing stack spanning influencer partnerships, SEO/content, HubSpot-driven lifecycle email, and PR in major German business press. Customer base consists entirely of individual consumers; over 2 million patients have used the platform since inception, with published peer-reviewed research (n=11,456) in the International Journal of Sexual Medicine and dermatology providing scientific credibility.

Wellster has raised approximately $100M+ in equity (Series A $40M in 2021, Series B $60M total in 2022) plus a €10M follow-on debt line from Claret Capital Partners in March 2026. FY2025 revenue reached €50M with ~70% year-over-year growth and first-time full-year profitability, making it the first German digital health provider to reach this milestone. In March 2026, Wellster launched GoLighter in Sweden as its first international market.

Name

Wellster Healthtech Group

Legal name

Wellster Healthtech Group GmbH

Website

https://wellsterhealth.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

51–100 employees

Short description

Wellster Healthtech Group operates a multi-brand Direct-to-Patient telemedicine ecosystem in Europe, serving over 2 million patients across men's health, women's health, obesity (GLP-1), hair loss, cannabis, and self-testing via German-licensed physicians.

Ownership category

akta.pro rank

Product category

Direct-to-Patient Telemedicine

NAICS

Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

Endocrinology & Diabetes Telemedicine Platforms (HLALAGAD), Primary Care & General Medicine Virtual Care (HLALAAAA)

Keywords

• Direct-to-patient telemedicine
• Digital health platform
• Online prescription services
• Telemedicine consultations
• Digital healthcare ecosystem

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Supply Chain, Others

Revenue model

1. Telemedicine Consultations: Direct-to-consumer telemedicine services providing digital medical consultations with German-licensed physicians for various health conditions including erectile dysfunction, obesity, hair loss, and general health concerns
2. Prescription Medications: Integrated prescription fulfillment through telemedicine consultations, providing patients with medically supervised access to prescription medications with delivery to patients
3. OTC Products: Sale of over-the-counter health products through branded platforms including medical self-tests

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Wellster Healthtech Group operates a Direct-to-Patient digital health platform providing asynchronous and synchronous telemedicine consultations with German-licensed physicians, integrated prescription fulfillment, and OTC health products across multiple condition-specific sub-brands (men's health, obesity, women's health, hair loss, medical cannabis, self-testing). The ecosystem has served over 2 million patients and is backed by a German-based Medical Advisory Board, Real-World Evidence data infrastructure, and 'Made in Germany' data processing standards.

Product overview

Wellster Healthtech Group operates a multi-brand digital health ecosystem centered on direct-to-patient telemedicine. The platform integrates a portfolio of seven named sub-brands targeting distinct health conditions: GoLighter (GLP-1-based obesity/weight management), GoSpring (men's health/erectile dysfunction), MySummer (women's health), MySpring (hair loss), GoEasy (medical cannabis), Easy-Testen (medical self-tests), and Apons (specialized health conditions), all supported by the core Wellster Medical telemedicine infrastructure. The ecosystem is unified by shared medical governance (Medical Advisory Board), German-based data processing, and an integrated care model connecting access, treatment, and follow-up. The company also maintains a separate general medical consultation platform under Wellster Medical. The company expanded internationally for the first time in 2026, launching GoLighter in Sweden as a European proof-of-concept market.

Differentiator

Problem solved

Functional benefit

Brands

• GoSpring (gospring.de): Men's health platform addressing erectile dysfunction and related conditions
• GoLighter (golighter.de)
• Summer / MySummer (mysummer.de)
• MySpring (myspring.com)
• Apons (apons.eu)
• WellsterMedical (wellstermedical.com)
• Easy-Testen (easy-testen.de)
• GoEasy (goeasy.de)

Products and services

• GoSpring Men's health platform offering treatment for erectile dysfunction and related conditions via integrated telemedicine. Provides discreet online consultations with German-licensed physicians and prescription delivery for men's health patients.
• GoLighter GLP-1-based digital obesity therapy platform offering medically supervised weight loss treatments. Provides structured digital patient pathways including nutritional advice and ongoing medical supervision for individuals seeking weight management solutions.
• MySummer Women's health platform addressing female sexual health and related concerns through digital healthcare services, providing discreet telemedicine consultations and prescription fulfillment for women's health patients.
• MySpring Hair loss treatment platform providing digital consultations and prescriptions for hair restoration therapies via telemedicine.
• GoEasy Medical cannabis platform providing digital access to cannabis-based treatments via telemedicine consultations with regulatory-compliant prescription fulfillment.
• Easy-Testen Platform providing medical self-tests for various health conditions, enabling patients to conduct diagnostic assessments at home with privacy and convenience.
• Wellster Medical Digital health platform focused on general medical consultations and healthcare services delivered via telemedicine with German-licensed physicians.
• Apons Health platform providing services related to a specific health condition or treatment area within Wellster's digital health ecosystem.
• Wellster Healthtech Digital Health Ecosystem The overarching digital health ecosystem integrating Wellster's portfolio of direct-to-patient health portals. Provides the telemedicine infrastructure, medical advisory oversight, data processing on German servers, and regulatory compliance framework that underpins all sub-brands. Supports both synchronous and asynchronous telemedicine, structured patient triage, and integrated care delivery from consultation through prescription and delivery.

Quantifiable outcome

• 11,456 male patients treated via telemedicine, with study demonstrating improved access to healthcare especially for rural patients and those seeking care outside office hours
• +2 more outcomes

Named customers2 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered minor, core and strategic.

• NoventiminorStrategic or Co-development Partner · 22 September 2020Cooperation with Noventi, one of Germany's largest healthcare IT companies, expanding distribution and service capabilities for digital health offerings.
• Ludwig-Maximilians-Universität München (LMU Munich)coreStrategic or Co-development PartnerResearch cooperation with LMU Munich resulting in the world's first study on erectile dysfunction based on telemedical data. Published peer-reviewed research (11,456 patients) in the International Journal of Sexual Medicine. Partnership demonstrates scientific rigor and provides evidence-based credibility for the telemedicine model.
• Pharma Deutschland (Bundesverband der Pharmazeutischen Industrie)strategicStrategic or Co-development PartnerIndustry association membership providing regulatory guidance and industry representation for pharmaceutical and digital health companies in Germany.

Scale indicators10 records

Recent moves9 records

Expansion highlights7 records

Direct peers

• Numan: UK-headquartered D2C digital health clinic for men's health (erectile dysfunction, hair loss, testosterone) — directly comparable to GoSpring and MySpring in Wellster's portfolio.
• Zava (previously DrEd): European D2C online clinic operating in Germany, UK, France and Ireland providing prescription treatments for sensitive conditions — a directly comparable multi-condition telemedicine platform.
• DoktorABC: German D2C online clinic selling prescription and OTC medications via telemedicine across similar condition verticals (ED, contraception, hair loss, weight loss) — directly competes with Wellster's sub-brands in Germany.
• euroClinix: Pan-European online clinic offering prescription treatments for sensitive indications via telemedicine — a direct peer in the D2C prescription telehealth category.
• 121doc: European D2C online clinic providing prescription treatments across multiple condition verticals — operates the same D2C prescription model as Wellster's sub-brand portfolio.
• Apomeds: German D2C online pharmacy platform integrating prescription-based telemedicine for multiple indications — overlaps with Wellster's prescription + OTC digital clinic model.

Broad incumbents

• Hims & Hers Health: US-listed, large-scale D2C telehealth and consumer health company offering prescription + OTC across men's, women's, dermatology and primary care — same multi-condition D2C clinic archetype as Wellster but at vastly greater scale and US capital markets profile.
• Kry (Livi): Europe's largest general telehealth provider (Sweden-headquartered) operating across multiple EU markets — overlaps with Wellster in the Swedish market and general telemedicine infrastructure, though more focused on synchronous GP consultations.
• Doctolib: Dominant European healthcare booking and telemedicine platform — not a direct condition-specific Rx competitor but increasingly adding telehealth consultation capabilities that could overlap with WellsterMedical's general medicine vertical.

Regional players

• Doktor.se: Sweden's largest D2C telemedicine provider — now directly competes with Wellster's GoLighter in the Swedish market that launched March 2026, making it the most relevant regional incumbent for the new international beachhead.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/direct-health-services-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wellster Healthtech Group